Arginine metabolism in vascular biology and disease

被引:69
作者
Morris, SM [1 ]
机构
[1] Univ Pittsburgh, Sch Med, Dept Mol Genet & Biochem, Pittsburgh, PA 15261 USA
关键词
arginase; endothelium; hemolysis; nitric oxide;
D O I
10.1191/1358863x05vm601oa
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Arginine metabolism plays a major role in cardiovascular physiology and path ophysiology, largely via nitric oxide (NO)-dependent processes. It is becoming increasingly apparent, however, that arginine metabolic enzymes other than the NO synthases can also play important roles via both NO-dependent and -independent processes. There are three sources of arginine in vivo and at least five mammalian enzymes or enzyme families that utilize arginine as substrate. Changes in arginine availability or in production of the different end products of the various arginine metabolic pathways can have distinct and profound physiologic consequences. However, our knowledge regarding the complex interplay between these pathways at the level of the whole body, specific tissues, and even individual cells, is incomplete. This review will highlight recent findings in this area that may suggest additional avenues of investigation that will allow a fuller understanding of cardiovascular physiology in health and disease.
引用
收藏
页码:S83 / S87
页数:5
相关论文
共 44 条
  • [1] Abumrad N. N., 2004, Metabolic & Therapeutic Aspects of Amino Acids Clinical Nutrition, P595
  • [2] Arginase pathway in human endothelial cells in pathophysiological conditions
    Bachetti, T
    Comini, L
    Francolini, G
    Bastianon, D
    Valetti, B
    Cadei, M
    Grigolato, PG
    Suzuki, H
    Finazzi, D
    Albertini, A
    Curello, S
    Ferrari, R
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2004, 37 (02) : 515 - 523
  • [3] Arginine availability, arginase, and the immune response
    Bansal, V
    Ochoa, JB
    [J]. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2003, 6 (02) : 223 - 228
  • [5] Arginase reciprocally regulates nitric oxide synthase activity and contributes to endothelial dysfunction in aging blood vessels
    Berkowitz, DE
    White, R
    Li, DC
    Minhas, KM
    Cernetich, A
    Kim, S
    Burke, S
    Shoukas, AA
    Nyhan, D
    Champion, HC
    Hare, JM
    [J]. CIRCULATION, 2003, 108 (16) : 2000 - 2006
  • [6] The clinical pharmacology of L-arginine
    Böger, RH
    Bode-Böger, SM
    [J]. ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2001, 41 : 79 - 99
  • [7] Buga Georgette M., 1996, American Journal of Physiology, V271, pH1988
  • [8] Arginases I and II: do their functions overlap?
    Cederbaum, SD
    Yu, H
    Grody, WW
    Kern, RM
    Yoo, P
    Iyer, RK
    [J]. MOLECULAR GENETICS AND METABOLISM, 2004, 81 : S38 - S44
  • [9] Arginase inhibition increases nitric oxide production in bovine pulmonary arterial endothelial cells
    Chicoine, LG
    Paffett, ML
    Young, TL
    Nelin, LD
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2004, 287 (01) : L60 - L68
  • [10] Plasma membrane transporters for arginine
    Closs, EI
    Simon, A
    Vékony, N
    Rotmann, A
    [J]. JOURNAL OF NUTRITION, 2004, 134 (10) : 2752S - 2759S